Prof. Moji Adeyeye, Director-General of National Agency for Food, Drug Administration and Control (NAFDAC), says the country is working toward producing 60 per cent of its pharmaceutical products locally to reduce the over-dependence on international companies.
Adeyeye said this at a virtual conference with the theme “Seizing the Moment: Providing Faster Access to Quality Medical Products during COVID-19 and Beyond”, organised by the Management Sciences for Health (MSH) in partnership with Deloitte, a multinational professional services network.
The conference which had participants from some African countries was specifically on novel approaches emerging from COVID-19 response that can be effectively leveraged to respond to the pandemic, especially in Africa.
Adeyeye said the coronavirus pandemic was an eye opener to the world and as such efforts should be made to accelerate progress toward universal health coverage.
“Right now, we manufacture only 30 per cent of our…
Source: Vanguard Newspaper